Right-wing attacks blaming SVB’s collapse on “wokeness” are intended to divert attention from the de-regulatory actions that might have contributed to this outcome. […]
Silicon Valley Bank, which does business with roughly half of the nation’s tech and biotech companies, failed on Friday. Now biotech startups are left wondering: Who’s going to finance the… […]
In Theranos’s backyard, a health tech leader is taking another crack at home blood testing. He wants to make sure the process is bulletproof. […]
“There was a lot of pressure to commercialize this way too early,” said Mindstrong co-founder Paul Dagum. […]
Out of stealth, Rezo Therapeutics seized on #JPM23 to tell its story. […]
Hospitals’ message at #JPM23: This year will be about increasing revenue by expanding footprints and hiking prices. […]
The balance of power between biotech startups and big pharma has shifted — but Bayer executive Marianne De Backer is still looking for deals. […]
Medicare Advantage providers Oak Street & Agilon Health chart out ambitious growth on day one of #JPM23. […]
Four life science companies have announced acquisitions worth roughly $4.5 billion in total, raising hopes that 2023 will yield more M&A. […]
Silicon Valley venture capital giant a16z has struck a surprising new partnership with a rural health system in upstate New York. Here’s what’s in it for both of them. […]
Copyright © 2022 Biotech Networks, LLC
